BioWorld MedTech

Jan. 13, 2016

View Archived Issues

J.P. Morgan Healthcare Conference 2016: Medtronic to return $5 billion of freed cash to shareholders

SAN FRANCISCO — As Medtronic plc (Dublin) approaches the anniversary of its blockbuster Covidien deal, which closed a year ago this month, the company is making strides to prove the $42.9 billion acquisition is paying off. Read More

J.P. Morgan Healthcare Conference 2016: Heartware suffers more heartache over MVAD, trial in limbo after thrombus events

Read More

Inside the Beltway: Califf breezes through Senate hearing for top job at the FDA

Read More

Company accused of lowering evidence bar: PDAC once again votes to recommend Probuphine implant

Read More

Silimed issues still not resolved: Sientra's new CEO updates physicians over crisis with Brazilian operations

Read More

Daily M&A: Smith & Nephew acquires BST-Cargel assets from Piramal Healthcare

Read More

Financings: Accuray closes $70M straight debt agreements with Cerberus

Read More

Patent Watch: Entac gets patent for technology to predict gastrointestinal impairment

Read More

World in Review: Polaris using DNAnexus for clinical omics

Read More

People in Places

Read More

product briefs

Read More

MDD's Oncology Extra

Read More